BofA analyst Brad Sills raised the firm’s price target on UiPath to $22 from $20 and keeps a Buy rating on the shares after the company reported “solid” Q2 results and raised its full year guidance. The firm, which believes that NRR “has likely found the bottom” with “significantly easier” comparisons ahead in the second half, cites better revenue and free cash flow estimates for its increased price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PATH:
- UiPath (NYSE:PATH): Analysts Issue Hold Ratings Despite Strong Q2 Results
- UiPath (NYSE:PATH) Soars on Impressive Q2 Numbers
- UiPath price target raised to $18 from $16 at Barclays
- Uipath Inc Earnings Update: Did it Beat Estimate Forecasts?
- UiPath jumps 6% to $17.21 after Q2 earnings beat, guidance raise